# FLUDEOXYGLUCOSE F18
> **ANDA203811** · Abbreviated New Drug Application (Generic) · Sponsor: UCLA BIOMEDICAL · Approved 2013-06-27
## Drug
- **FDA Application Number:** ANDA203811
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FLUDEOXYGLUCOSE F18
- **Generic name:** Fludeoxyglucose F-18
- **Active ingredients:** FLUDEOXYGLUCOSE F-18
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** UCLA BIOMEDICAL
- **First approval:** 2013-06-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203811)
---
*MORVS · CC0 1.0*